Tumor-infiltrating lymphocytes and outcome in merkel cell carcinoma, a virus-associated cancer

OncoImmunology

Volumn 1, Issue 8, 2012, Pages 1420-1421

  Sihto, Harri ^a   Joensuu, Heikki ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cytotoxic T cells; Merkel cell carcinoma; Merkel cell polyomavirus; Survival; Tumor infiltrating lymphocytes

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN G ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN P53; PROTEIN VP1; PROTEIN VP2; RETINOBLASTOMA PROTEIN; VIRUS DNA;

CANCER IMMUNOLOGY; CANCER PATIENT; CANCER RISK; CANCER TISSUE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CYCLE REGULATION; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; GRAFT RECIPIENT; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIGHT EXPOSURE; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MERKEL CELL POLYOMAVIRUS; MERKEL CELL TUMOR; NATURAL KILLER CELL; NOTE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN CARCINOGENESIS; SURVIVAL; T LYMPHOCYTE SUBPOPULATION; TUMOR ASSOCIATED LEUKOCYTE; VIRUS LOAD;

EID: 84877752598     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.21120     Document Type: Note

References (10)

1. Girschik J, Thorn K, Beer TW, Heenan PJ, Fritschi L. Merkel cell carcinoma in Western Australia: a population-based study of incidence and survival. Br J Dermatol 2011; 165:1051-7.
2. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319:1096-100.
3. Bhatia S, Afanasiev O, Nghiem P. Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer. Curr Oncol Rep 2011; 13:488-97.
4. Sihto H, Kukko H, Koljonen V, Sankila R, Böhling T, Joensuu H. Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma. Clin Cancer Res 2011; 17:4806-13.
5. Houben R, Shuda M, Weinkam R, Schrama D, Feng H, Chang Y, et al. Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J Virol 2010; 84:7064-72.
6. Paulson KG, Lemos BD, Feng B, Jaimes N, Peñas PF, Bi X, et al. Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc. J Invest Dermatol 2009; 129:1547-55.
7. Nardi V, Song Y, Santamaria-Barria JA, Cosper AK, Lam Q, Faber AC, et al. Activation of PI3K signaling in Merkel cell carcinoma. Clin Cancer Res 2012; 18:1227-36.
8. Paulson KG, Carter JJ, Johnson LG, Cahill KW, Iyer JG, Schrama D, et al. Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients. Cancer Res 2010; 70:8388-97.
9. Sihto H, Böhling T, Kavola H, Koljonen V, Salmi M, Jalkanen S, et al. Tumor infiltrating immune cells and outcome of merkel cell carcinoma: a populationbased study. Clin Cancer Res 2012; 18:2872-81.
10. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006; 439:682-7.